Anti-inflammatory agent
AssigneeWatanabe Oyster Laboratory Co., Ltd.
InventorMitsugu WATANABE
Life of this patent
Estimating the term…
Loading patent…
AssigneeWatanabe Oyster Laboratory Co., Ltd.
InventorMitsugu WATANABE
Estimating the term…
[Problem] The present invention demonstrates that, when added to the culture, DHMBA inhibits the proliferation of mouse inflammatory macrophage RAW264.7 cells, promotes their cell death, and reduces their cell number. It also demonstrates that DHMBA suppresses the increased production of inflammatory cytokines in RAW264.7 cells cultured with LPS, and in particular, DHMBA treatment suppresses osteoclast formation in RAW264.7 cells stimulated with LPS. Thus, the present invention provides a useful means of treating inflammatory diseases using DHMBA. [Solution] The present invention is characterized by having an anti-inflammatory effect by including 3,5-dihydroxy-4-methoxy benzyl alcohol (DHMBA) as an active ingredient.
An anti-inflammatory agent comprising 3,5-dihydroxy-4-methoxy benzyl alcohol (DHMBA) as an active ingredient, the agent having an anti-inflammatory effect.
An inflammatory macrophage activity inhibitor comprising 3,5-dihydroxy-4-methoxybenzyl alcohol (DHMBA) as an active ingredient, the inhibitor having an effect of suppressing activity of an inflammatory macrophage.
A RAW264.7 cell proliferation inhibitor, comprising 3,5-dihydroxy-4-methoxybenzyl alcohol (DHMBA) as an active ingredient, the inhibitor having an effect of suppressing proliferation of RAW264.7 cells.
A proliferation inhibitor for RAW264.7 cells cultured with LPS, comprising 3,5-dihydroxy-4-methoxybenzyl alcohol (DHMBA) as an active ingredient, the inhibitor having an effect of suppressing proliferation of RAW264.7 cells cultured with LPS.
A RAW264.7 cell death promoter, comprising 3,5-dihydroxy-4-methoxybenzyl alcohol (DHMBA) as an active ingredient, the promoter having an effect of promoting death of RAW264.7 cells.
An inflammatory cytokine production inhibitor for RAW264.7 cells, comprising 3,5-dihydroxy-4-methoxybenzyl alcohol (DHMBA) as an active ingredient, the inhibitor having an effect of suppressing inflammatory cytokine production in RAW264.7 cells.
An inflammatory cytokine production inhibitor for RAW264.7 cells, comprising 3,5-dihydroxy-4-methoxy benzyl alcohol (DHMBA) as an active ingredient, the inhibitor having an effect of suppressing inflammatory cytokine production in RAW264.7 cells.
An osteoclast formation inhibitor for RAW264.7 cells, comprising 3,5-dihydroxy-4-methoxybenzyl alcohol (DHMBA) as an active ingredient, the inhibitor having an effect of suppressing osteoclast formation in RAW264.7 cells.
Dependencies are inferred from the claim text.